Login / Signup

Conjunctival Tarsal Actinic Keratosis Treated with Interferon Alfa-2b: A Rare Case Report and Literature Review.

Mónica Gimeno-CarreroMaría-Jesús Suárez-FernándezBeatriz Alonso-MartínAlmudena De-Pablo-CabreraMaría-Concepción Garrido-RuízEnrique Mencía-Gutiérrez
Published in: Case reports in ophthalmological medicine (2021)
Conjunctival neoplasia is one of the most frequent tumors in the eye. Actinic keratosis (AK) or solar keratosis is a precancerous lesion that is included with other epithelial tumors. This alteration does not break the basal membrane. There is enough evidence of successful outcomes to consider interferon alfa-2b (IFN alfa-2b) as the first choice of treatment for this type of tumors. In addition, side effects are mild and uncommon. We report a case in an 83-year-old woman who was referred to evaluate a leukoplakia in the tarsal conjunctiva of the lower left eyelid that measured 1 cm in diameter. Pathological study revealed AK. After the INF alfa-2b treatment, we observed conjunctival hyperemia, noninfiltrated upper nasal de-epithelization, and inferior nasal bulla. AK with presentation in conjunctiva is rarely described and in tarsal conjunctiva is exceptional. It is the first case published with only tarsal conjunctiva affectation.
Keyphrases
  • replacement therapy
  • dendritic cells
  • immune response
  • case report
  • type diabetes
  • single cell
  • systematic review
  • high grade
  • combination therapy
  • skeletal muscle